Midorikawa et al. [57] analyzed 52 early-stage and 108 overt HCC specimens using genome sequencing and found that mutations in the p53/RB1, PI3K-AKT, and WNT pathways are frequently observed in HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.